Post-earnings recap
Reported
Thu, Aug 11, 2022
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
CorMedix Inc. reported a narrower loss per share than expected, which contributed to a positive stock reaction, with shares rising by over 10%. However, there was no revenue reported or guidance provided, leaving investors with limited insights into future performance. The market's response suggests some optimism despite the lack of detailed information.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.19 | N/A | +5.00% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.